FDA Adverse Event Injury Summary report: N

APTIMA HPV SCREENING ASSAY

MDR report key: 23866139 · Received December 22, 2025

Report

Report Number
2024800-2025-00077
Event Type
Injury
Date Received
December 22, 2025
Date of Event
December 8, 2025
Manufacturer
HOLOGIC, INC.
Product Code
OYB
UDI-DI
15420045500051
PMA / PMN Number
P100042
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

HOLOGIC REVIEWED THE PANTHER LOGS AND WORKLISTS AND NOTED THERE WERE NO INDICATIONS OF INSTRUMENT OR REAGENT PREPARATION ISSUES; THE MOST LIKELY CAUSE OF THE DISCREPANT RESULTS WAS LOW TARGET IN THE SAMPLES OR SAMPLE MISHANDLING/CONTAMINATION. HOLOGIC PERFORMED A RISK ASSESSMENT AND NOTED NO PRODUCT IMPACT. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS ISSUE.

Description of Event or Problem · 0

ON (B)(6) 2025, A CUSTOMER REPORTED TO HOLOGIC DISCREPANT RESULTS FOR SAMPLE ID¿S (SID) (B)(6) WHILE USING THE APTIMA HPV ASSAY ML 919387 ON THEIR PANTHER PLUS INSTRUMENT (SN (B)(6)). ON (B)(6) 2025, THE CUSTOMER INITIALLY TESTED THESE SID ON WORKLIST (WL) (B)(4) AND RECEIVED A POSITIVE RESULT FOR SID (B)(6), AND A NEGATIVE RESULT FOR SID (B)(6). PER CUSTOMER LAB POLICY, A POSITIVE RESULT MUST BE MANUALLY APPROVED, AND A NEGATIVE RESULT GETS REPORTED AUTOMATICALLY. ON (B)(6) 2025, THE CUSTOMER RETESTED THESE SAMPLES IN WL (B)(4) ON A DIFFERENT PANTHER INSTRUMENT (SN (B)(6)) AND RECEIVED DISCREPANT RESULTS: SID (B)(6) AND SID (B)(6) TESTED NEGATIVE AND SID (B)(6) TESTED POSITIVE. CUSTOMER CONFIRMED THE HPV NEGATIVE RESULTS WERE REPORTED OUT. HOLOGIC HAS NOT BEEN INFORMED OF ANY PATIENT TREATMENT OR ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2318347 APTIMA HPV SCREENING ASSAY KIT, RNA DETECTION, HUMAN PAPILLOMAVIRUS OYB HOLOGIC, INC. 919387 15420045500051

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown